IMARC Group, a leading market research company, has recently releases report titled “Pharmaceutical Drug Delivery Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2023-2028.” The study provides a detailed analysis of the industry, including the global pharmaceutical drug delivery market size, growth, share, trends, and forecasts. The report also includes competitor and regional analysis and highlights the latest advancements in the market.

Industry Overview of Pharmaceutical Drug Delivery

Pharmaceutical drug delivery refers to the science and technology involved in delivering therapeutic substances to specific sites within the body where they can exert their intended pharmacological effects. It comprises oral, injectable, transdermal, and inhalation drug delivery, where inhalers and nebulizers are used to deliver medications directly to the respiratory system, making them effective for treating respiratory conditions. It is convenient, patient-friendly, and can enhance adherence to treatment regimens. It ensures drugs reach the intended site, increasing their effectiveness. It plays an important role in enhancing the efficacy and safety of medications, ultimately improving patient outcomes.

How Big Is the Pharmaceutical Drug Delivery Market?

The global pharmaceutical drug delivery market size reached US$ 1,325 Billion in 2022. Looking forward, IMARC Group expects the market to reach US$ 1,848 Billion by 2028, exhibiting a growth rate (CAGR) of 5.5% during 2023-2028.

Request Sample Copy of This Report: https://www.imarcgroup.com/pharmaceutical-drug-delivery-market/requestsample

What are the growth prospects and trends in the pharmaceutical drug delivery industry?

At present, the increasing demand for pharmaceutical drug delivery, as they are crucial in personalized medicine and customizing treatments to individual patients based on their unique needs, represents one of the crucial factors impelling the growth of the market. 

Besides this, the rising employment of pharmaceutical drug delivery to manage chronic diseases, alleviate symptoms, treat acute conditions, and even deliver vaccines is propelling the growth of the market. In addition, the growing occurrence of various chronic ailments among the masses, such as diabetes, arthritis, thyroiditis, and cardiovascular diseases, is offering a favorable market outlook. 

Apart from this, increasing advancements in pharmaceutical drug delivery to broaden treatment possibilities are strengthening the growth of the market.

What is included in market segmentation?

The report has segmented the market into the following categories:

Breakup by Route of Administration:

  • Oral Drug Delivery
  • Injectable Drug Delivery
  • Topical Drug Delivery
  • Ocular Drug Delivery
  • Pulmonary Drug Delivery
  • Implantable Drug Delivery
  • Transmucosal Drug Delivery
  • Nasal Drug Delivery

Breakup by Application:

  • Infectious Diseases
  • Cancer
  • Cardiovascular Diseases
  • Diabetes
  • Respiratory Diseases
  • Central Nervous System Disorders
  • Autoimmune Diseases
  • Others

Breakup by End User:

  • Hospitals
  • Ambulatory Surgery Centers
  • Home Care Settings
  • Diagnostic Centers
  • Others

Breakup by Region:

  • North America: (United States, Canada)
  • Asia Pacific: (China, Japan, India, South Korea, Australia, Indonesia, Others)
  • Europe: (Germany, France, United Kingdom, Italy, Spain, Russia, Others)
  • Latin America: (Brazil, Mexico, Others)
  • Middle East and Africa

Who are the key players operating in the industry?

The report covers the major market players including:

  • AbbVie Inc.
  • Amgen Inc.
  • AstraZeneca plc
  • Becton Dickinson and Company
  • Eli Lilly and Company
  • GSK plc
  • Johnson & Johnson
  • Merck KGaA
  • Novartis AG
  • Pfizer Inc.
  • Sanofi S.A.

If you require any specific information that is not covered currently within the scope of the report, we will provide the same as a part of the customization.

About Us

IMARC Group is a leading market research company that offers management strategy and market research worldwide. We partner with clients in all sectors and regions to identify their highest-value opportunities, address their most critical challenges, and transform their businesses.

IMARC Group’s information products include major market, scientific, economic and technological developments for business leaders in pharmaceutical, industrial, and high technology organizations. Market forecasts and industry analysis for biotechnology, advanced materials, pharmaceuticals, food and beverage, travel and tourism, nanotechnology and novel processing methods are at the top of the company’s expertise.

Contact US

IMARC Group

134 N 4th St. Brooklyn, NY 11249, USA

USA: +1-631-791-1145 | Asia: +91-120-433-0800

Email: sales@imarcgroup.com

Follow us on Twitter: @imarcglobal

LinkedIn: https://www.linkedin.com/company/imarc-group/mycompany/